Full Coverage

Astec Lifesciences — IPO: Avoid

                   
thehindubusinessline.com
Oct 31, 2009
 
Story Timeline:  26 days

Investors can refrain from subscribing to the Initial Public Offering (IPO) from Astec Lifesciences, being made to fund expansion projects for the manufacture of agrochemical and pharma ingredients. Investors can refrain from... [read full story]                    

powered by
Add Comment
Latest article on this story:

Expensive formulation

 business-standard.com Nov 1, 2009
First article on this story:

Expensive formulation

 business-standard.com Nov 1, 2009
Selected publications with coverage of this story:
thehindubusinessline.com business-standard.com
RELATED
No documents found.